Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating - Virax Biolabs Group ( NASDAQ:VRAX )
HC Wainwright initiated coverage on Virax Biolabs with a Buy rating and a $3 price target, citing strong market potential. ViraxImmune platform aims to diagnose T-cell exhaustion in post-viral syndromes, with FDA discussions set for mid-2025. The 'Trade of the Day' is now live.
Baltic Horizon Fund consolidated audited results for 2024
Management Board of Northern Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund ( the Fund ) for the twelve months of 2024. The financial results remained unchanged compared to the preliminary disclosure on 17 February 2025.
JSHASH Announces Launch of Trusted Best Free Bitcoin Cloud Mining Option in 2025 - Allowing Users to Earn Passive Income from Home
Minneapolis, USA, March 31, 2025 ( GLOBE NEWSWIRE ) -- Reiterating its support for Proof-of- Work ( PoW ) mining-a practice that advances the larger cryptocurrency sector-the U.S.
A Closer Look at Atlassian's Options Market Dynamics - Atlassian ( NASDAQ:TEAM )
Deep-pocketed investors have adopted a bearish approach towards Atlassian TEAM, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data - Vertex Pharmaceuticals ( NASDAQ:VRTX )
Vertex will not advance VX-264 trials after the study failed to meet efficacy endpoints, despite being generally safe and well tolerated. Zimislecel, Vertex's islet cell therapy, remains on track for Phase 3 completion in 2025, with regulatory submissions expected in 2026.
ROSEN, A LEADING NATIONAL FIRM, Encourages Atkore Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATKR - Atkore ( NYSE:ATKR )
NEW YORK, March 31, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Atkore Inc. ATKR between August 2, 2022 and February 3, 2025, both dates inclusive ( the "Class Period" ) , of the important April 23, 2025 lead ...
'Dire consequences' if Musk accesses SEC - US lawmaker
The top Democrat on the US House Financial Services Committee issued a warning after reports suggested that Tesla CEO Elon Musk's "government efficiency" team would be given access to data and systems at the Securities and Exchange Commission ( SEC ) .In a March 31 notice, Representative Maxine ...
Peter Schiff Sounds The Alarm: 'Same Mistake Again' Could Trigger Economic Firestorm - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , iShares Core U.S. Aggregate Bond ETF ( ARCA:AGG ) , Invesco DB Commodity Index Tracking Fund ( ARCA:DBC ) , SPDR Select Sector Fund - Technology ( ARCA:XLK )
Peter Schiff warns tariffs will fuel inflation, weaken the dollar and trigger a crisis worse than the 1970s. Fed's response to economic weakness could ignite runaway inflation, compounding the damage from rising interest rates and deficits. Feel unsure about the market's next move?
Shoptalk 2025: Goldman Sachs Analyst Unveils Insights On AI, Video, Retail And Stock Picks - Gap ( NYSE:GAP ) , Amazon.com ( NASDAQ:AMZN )
AI, video content, and personalized shopping are shaping the future of eCommerce, driving higher engagement and conversions. Google, Amazon, and Walmart are leading in retail media, leveraging AI to enhance customer experience and boost profits. Feel unsure about the market's next move?
Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad - 31 March 2025
At the close of business on 31 March 2025, Morten Opstad, chair of the board of IDEX Biometrics, held the following voting rights in IDEX, for the extraordinary general meeting on 11 April 2025.











